Local 12: Diabetes study focuses on how long blood sugar control can be maintained
The University of Cincinnati's Robert Cohen, MD, spoke with Local 12 about the GRADE study.
"This was a type two diabetes study, and whereas most studies are looking at how good the blood sugar control can be, this study was focused on how long the blood sugar control can be maintained,” said Cohen, a professor in UC's College of Medicine and UC Health endocrinologist.
Maintaining blood sugar control near normal levels can lower the risk of further complications like heart and kidney disease and vision problems for people with diabetes, Cohen said.
The years-long study found medications now known as Ozempic or Mounjaro were some of the best at maintaining long-term blood sugar control.
“That and insulin itself really did the best job of preserving glycemic blood sugar control,” Cohen said.
As the research continues, Cohen said the team will move beyond drugs that bring down blood sugar levels to evaluate drugs that preserve insulin-producing cells.
Watch or read the Local 12 story.
Featured photo at top of a semaglutide injection pen. Photo/aprott/iStock.
Related Stories
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.